Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ICUI | ICU MED INC | Healthcare | 254,291.0 | $32.8M | 4.61% | -86K | -25.4% | $129.15 | -4.7% |
| 2 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 315,972.0 | $30.7M | 4.32% | -47K | -13.1% | $97.25 | +48.5% |
| 3 | PACS | PACS GROUP INC | Financial Services | 604,180.0 | $25.6M | 3.60% | -541K | -47.3% | $42.42 | -13.2% |
| 4 | PFE | PFIZER INC | Healthcare | 1,464,129.0 | $19.4M | 2.73% | -739K | -33.5% | $13.25 | +91.1% |
| 5 | LLY | ELI LILLY & CO | Healthcare | 20,696.0 | $19.0M | 2.67% | -11K | -35.2% | $919.77 | +7.4% |
| 6 | BIIB | BIOGEN INC | Healthcare | 96,289.0 | $17.7M | 2.48% | -66K | -40.6% | $183.33 | +3.9% |
| 7 | COGT | COGENT BIOSCIENCES INC | Healthcare | 352,590.0 | $13.6M | 1.91% | -216K | -38.0% | $38.49 | -18.5% |
| 8 | NUVL | NUVALENT INC | Healthcare | 129,950.0 | $13.3M | 1.87% | -139K | -51.7% | $102.45 | -2.5% |
| 9 | — | ASCENDIS PHARMA A/S | — | 51,895.0 | $11.9M | 1.67% | -34K | -39.4% | $228.73 | — |
| 10 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 67,332.0 | $11.5M | 1.62% | -61K | -47.4% | $171.43 | -9.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.2%
Financial Services
3.8%